VCNX · Vaccinex, Inc.
$1.06
At close · Dec 18
Going-concern doubt
— flagged Apr 15, 2025
Substantial doubt about the company's ability to continue as a going concern.
“We will require additional capital to finance our operations to continue as a going concern, which may not be available to us on acceptable terms, if at all. As a result, we may not complete the development and commercialization of our product candidates or develop new product candidates and have substantial doubt about our ability to continue as a going concern.”View the 10-K filed Apr 15, 2025
Market Cap
$2.94M
Shares
2.68M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$601K
+5.4%
FY2024
Net Income
-$18.63M
+8%
FY2024
Gross Margin
99.68%
+37.7pp
FY2020
Operating Margin
-3117.3%
+897.6pp
FY2024
Diluted EPS
-$8.88
+79.7%
FY2024
Operating Cash Flow
-$16.19M
+24.3%
FY2024
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| — | $601K | $570K | $275K | $900K | $625K | $523K | $724K | $90K | — | |
| — | — | — | — | — | $2000 | $199K | $1.03M | $160K | — | |
| — | — | — | — | — | $623K | $324K | -$309K | -$70K | — | |
| — | — | — | — | — | 99.68% | 61.95% | -42.68% | -77.78% | — | |
| — | $12.55M | $16.57M | $13.98M | $17.16M | $21.55M | $25.67M | $22.35M | $16.55M | — | |
| — | $6.79M | $6.88M | $6.2M | $6.23M | $7.41M | $6.67M | $4.62M | $4.48M | — | |
| — | — | — | — | — | — | $249K | $223K | $206K | — | |
| — | $19.34M | $23.46M | $20.18M | $23.39M | $28.96M | $32.54M | $28.01M | $21.19M | — | |
| — | -$18.74M | -$22.89M | -$19.91M | -$22.49M | -$28.33M | -$32.02M | -$27.28M | -$21.1M | — | |
| — | -3117.3% | -4014.91% | -7238.55% | -2498.89% | -4532.96% | -6121.41% | -3768.09% | -23448.89% | — | |
| — | — | — | — | — | — | -$31.77M | -$27.06M | -$20.9M | — | |
| — | $2000 | $1000 | $2000 | $809K | $489K | — | $392K | $1.36M | — | |
| — | $41K | $912K | $93K | $43K | -$31K | $152K | $165K | -$40K | — | |
| — | -$18.63M | -$20.25M | -$19.82M | -$22.38M | -$28.85M | -$31.86M | -$29.52M | -$18.76M | — | |
| — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| — | -$18.63M | -$20.25M | -$19.82M | -$22.38M | -$28.85M | -$31.86M | -$29.52M | -$18.72M | — | |
| — | -3100.5% | -3552.81% | -7205.45% | -2486.67% | -4616.16% | -6092.35% | -4077.07% | -20802.22% | — | |
| $0 | — | — | — | $0 | $0 | $0 | $0 | -$37K | — | |
| — | -$18.63M | -$20.25M | -$19.82M | -$22.38M | -$28.85M | -$31.86M | -$29.52M | — | — | |
| USD/shares | — | -$8.88 | -$43.68 | -$98.05 | -$163.80 | — | — | — | — | — |
| USD/shares | — | -$8.88 | -$43.68 | -$98.05 | -$163.80 | — | — | — | — | — |
| shares | — | 2.1M | 463.65K | 202.08K | 137.38K | 89.46K | 61.34K | 24.87K | 5247.319 | — |
| shares | — | 2.1M | 463.65K | 202.08K | 137.38K | 89.46K | 61.34K | 24.87K | 5247.319 | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.